Side-by-Side Industry-Academic Partnerships Are Wave of Future

Clinical Trials Advisor
To meet the dual challenges of drug discovery — developing new compounds faster and at less cost, drugmakers should consider forming more integrated partnerships where company staff and academic scientists work side-by-side, one expert suggests.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00